Breath tester for cancer detection trialed in the UK

The video discusses a clinical trial for a new breath test device, Breath Biopsy, developed by Al Stone Medical. The trial involves 1500 participants, including cancer patients and healthy individuals. The device, resiva breath sampler, analyzes volatile organic compounds (VOCs) in exhaled breath to detect cancer. Participants breathe into the device for 10 minutes, and samples are sent to a Cambridge lab for analysis. The trial targets several cancer types, including esophageal, stomach, kidney, bladder, prostate, liver, and pancreatic cancer.

What is the main purpose of the Breath Biopsy device?

How many participants will be involved in the clinical trial?

What are volatile organic compounds (VOCs) and why are they significant in this study?

Describe the process participants will undergo during the trial.

What types of cancer are being tested in this trial?